Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Doxazosin 4 MG Oral Tablet

Known as: DOXAZOSIN MESYLATE 4 mg ORAL TABLET [Doxazosin], DOXAZOSIN MESYLATE 4 mg ORAL TABLET [Doxazosin mesylate], DOXAZOSIN MESYLATE 4MG TAB 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
This study sought to investigate the clinical efficacy and safety of combined oral therapy with sildenafil and doxazosin GITS… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2005
2005
BACKGROUND The selective alpha 1-adrenoceptor antagonist doxazosin in both standard formulation and gastrointestinal therapeutic… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Previous studies have shown that a single nighttime dose of standard doxazosin, an α-adrenergic antagonist, reduces blood… Expand
Is this relevant?
2004
2004
An analysis is presented to compare the efficacies of the doxazosin gastrointestinal therapeutic system (doxazosin-GITS) and… Expand
Is this relevant?
2003
2003
OBJECTIVE To compare the effects of the doxazosin gastrointestinal therapeutic system, extended-release (doxazosin-GITS… Expand
Is this relevant?
2003
2003
OBJECTIVE To investigate the effect of the doxazosin gastrointestinal therapeutic system (GITS) on the 24 h blood pressure (BP… Expand
Is this relevant?
2003
2003
The objective of this prospective, randomized, open‐label, parallel‐arm comparative study, with a 4‐month follow‐up, was to… Expand
Is this relevant?
2001
2001
OBJECTIVE To report an integrated analysis of two previous studies fully characterizing the clinical utility of the controlled… Expand
Is this relevant?
2000
2000
Background: The α1–blocker doxazosin mesylate is an established efficacious and welltolerated treatment for benign prostatic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1999
1999
The alpha 1-blocker doxazosin is a well-established therapy for hypertension and benign prostatic hyperplasia; however, in its… Expand
Is this relevant?